Turkish Medical Student Journal

Turkish Medical Student Journal

IL-17/TNF-α BISPECIFIC ANTIBODIES AS NEW THERAPEUTIC APPROACH TO RHEUMATOID ARTHRITIS

Yazarlar: Muhammad Luthfi ADNAN

Cilt 7 , Sayı 1 , 2020 , Sayfalar 37 - 40

Konular:Tıp

Anahtar Kelimeler:Bispecific antibodies,Rheumatoid arthritis,Therapeutics

Özet: Rheumatoid arthritis is a systemic autoimmune disease characterized by chronic inflammation causing swelling in the joints. IL17/TNF-α bispecific antibodies are antibodies that can bind to two different types of epitopes and work on two different types of receptors. IL-17/TNF-α bispecific antibodies have anti-inflammatory effects that act by blocking the inflammatory pathways of rheumatoid arthritis. Thus, bispecific antibodies have the potential to be the latest effective therapy against rheumatoid arthritis. Keywords: Bispecific antibodies, rheumatoid arthritis, therapeutics

ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır
KAYNAK GÖSTER
BibTex
KOPYALA
@article{2020, title={IL-17/TNF-α BISPECIFIC ANTIBODIES AS NEW THERAPEUTIC APPROACH TO RHEUMATOID ARTHRITIS}, volume={7}, number={37–40}, publisher={Turkish Medical Student Journal}, author={Muhammad Luthfi ADNAN}, year={2020} }
APA
KOPYALA
Muhammad Luthfi ADNAN. (2020). IL-17/TNF-α BISPECIFIC ANTIBODIES AS NEW THERAPEUTIC APPROACH TO RHEUMATOID ARTHRITIS (Vol. 7). Vol. 7. Turkish Medical Student Journal.
MLA
KOPYALA
Muhammad Luthfi ADNAN. IL-17/TNF-α BISPECIFIC ANTIBODIES AS NEW THERAPEUTIC APPROACH TO RHEUMATOID ARTHRITIS. no. 37–40, Turkish Medical Student Journal, 2020.
Atıf Görüntüle
PDF Görüntüle
Kaynak Görüntüle
Paylaş
Dergi Bilgileri